Fluorescence cholangiography for laparoscopic cholecystectomy: how, when, and why? A single-center preliminary study.
Bile duct injuries avoidance is a key goal of biliary surgery. In this prospective study we evaluate the safety and feasibility of ICG fluorescent cholangiography during laparoscopic cholecystectomy (LC) focusing on the optimization of timing and dose administration. From February to December 2022 f...
| Publicado en: | Minimally Invasive Therapy & Allied Technologies Vol. 32; no. 5; pp. 264 - 273 |
|---|---|
| Autores principales: | , , , , |
| Formato: | diagnostic images pictorial research tables/charts Journal Article |
| Publicado: |
Taylor & Francis Ltd
Oct2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=173928679&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 173928679 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 13645706 J4S jtl: Minimally Invasive Therapy & Allied Technologies issn: 13645706 maglogo: Y pubinfo: dt: Oct2023 vid: 32 iid: 5 pid: 377 pub: Taylor & Francis Ltd place: Philadelphia, Pennsylvania artinfo: ui: 173928679 172796088 173928679 173928679 10.1080/13645706.2023.2265998 173928679 ppf: 264 ppct: 9 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Fluorescence cholangiography for laparoscopic cholecystectomy: how, when, and why? A single-center preliminary study. aug: au: Fassari, Alessia Bianucci, Andrea Lucchese, Sara Santoro, Emanuele Lirici, Marco Maria affil: Department of Surgical Oncology, San Giovanni-Addolorato Hospital, Rome, Italy sug: subj: Cholecystectomy, Laparoscopic Methods Cholangiography Methods Fluorescent Dyes Administration and Dosage Administration, Intravenous Human Biliary Tract Anatomy and Histology Retrospective Design Record Review Data Analysis Software Descriptive Statistics Bile Ducts Injuries Postoperative Complications ab: Bile duct injuries avoidance is a key goal of biliary surgery. In this prospective study we evaluate the safety and feasibility of ICG fluorescent cholangiography during laparoscopic cholecystectomy (LC) focusing on the optimization of timing and dose administration. From February to December 2022 fifty-four LC were performed with fluorescence imaging in our surgical department. 2.5 mg ICG were administered intravenously between 5 h and 24 h before surgery. Near-infrared fluorescent cholangiography (NIRF-C) was performed. Adequate fluorescence was evaluated by comparing agent accumulation in the gallbladder and the extrahepatic duct and the background of liver parenchyma. Biliary anatomy was identified in all cases. Median time of ICG administration was 11 h previous surgery and three groups of patients were identified: group A receiving ICG 5–9 h, group B 10–14 h, group C 15–24 h before surgery. Peak contrast was gained in group B, with minimal fluorescence of liver parenchyma and more intense visibility of the biliary tract. Intraoperative cholangiogram was unnecessary in all cases. Fluorescent cholangiography during LC is safe and feasible overcoming the limits of other techniques available. 2.5 mg ICG administered 10–14 h before surgery produces optimal outcomes for near-infrared (NIR) fluorescent cholangiography. pubtype: Academic Journal doctype: diagnostic images pictorial research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|